Iafrate: #AMP2017 Clin char of ROS1-rearr NSCLC 1% prevalence - amazing crizotinib resp. PFS 20 mos vs 10 mos https://t.co/30J7mCokU1

3:28pm November 17th 2017 via Hootsuite